# Topical Application of AS101 for the Treatment of Atopic Dermatitis

> **NCT00927212** · PHASE2 · TERMINATED · sponsor: **BioMAS Ltd** · enrollment: 5 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** AS101 ointment

## Key facts

- **NCT ID:** NCT00927212
- **Lead sponsor:** BioMAS Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The trial started and halted due sponsor's considerations.
- **Last updated:** 2014-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927212, "Topical Application of AS101 for the Treatment of Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00927212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*